GLP-1 medications have moved quickly from medical treatment into everyday conversation.
Originally prescribed for type 2 diabetes, drugs like Ozempic and Wegovy are now widely discussed as weight-loss solutions and lifestyle upgrades. Social media is filled with before-and-after photos, influencers share personal routines, and ads promise fast access without long waits or complicated medical steps.
And that’s where the risk begins.
As popularity and demand for GLP-1 medications have grown, so